Get the Stockscreener App
28.32
3.23%
0.885
After Hours:
28.00
-0.32
-1.13%
Surmodics Inc stock is traded at $28.32, with a volume of 117.05K.
It is up +3.23% in the last 24 hours and down -2.75% over the past month.
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.
See More
Previous Close:
$27.43
Open:
$27.59
24h Volume:
117.05K
Relative Volume:
0.65
Market Cap:
$404.91M
Revenue:
$138.20M
Net Income/Loss:
$5.52M
P/E Ratio:
74.53
EPS:
0.38
Net Cash Flow:
$9.86M
1W Performance:
+3.13%
1M Performance:
-2.75%
6M Performance:
+2.46%
1Y Performance:
-24.74%
1-Day Range:
$27.40
$28.67
1-Week Range:
$26.73
$28.67
52-Week Range:
$26.00
$40.38
Surmodics Inc Stock (SRDX) Company Profile
Name
Surmodics Inc
Sector
Industry
Phone
(952) 500-7000
Address
9924 W 74TH ST, EDEN PRAIRIE, MN
Compare SRDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRDX
Surmodics Inc
|
28.32 | 392.26M | 138.20M | 5.52M | 9.86M | 0.38 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Surmodics Inc Stock (SRDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-07-25 | Upgrade | Lake Street | Hold → Buy |
| Jun-13-23 | Upgrade | Needham | Hold → Buy |
| Feb-13-23 | Downgrade | Needham | Buy → Hold |
| Jul-23-20 | Upgrade | Needham | Hold → Buy |
| Dec-11-19 | Downgrade | Needham | Buy → Hold |
| Nov-01-19 | Downgrade | Lake Street | Buy → Hold |
| Aug-01-19 | Reiterated | Needham | Buy |
| May-02-19 | Reiterated | Lake Street | Buy |
| May-02-19 | Reiterated | Needham | Buy |
| Feb-21-19 | Reiterated | Needham | Buy |
| May-16-18 | Reiterated | Needham | Buy |
| Mar-01-18 | Upgrade | Sidoti | Neutral → Buy |
| Feb-28-18 | Reiterated | Lake Street | Buy |
| Feb-28-18 | Initiated | Needham | Buy |
| Jul-14-17 | Initiated | Lake Street | Buy |
| Nov-21-16 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Oct-06-16 | Downgrade | Sidoti | Buy → Neutral |
| May-03-16 | Reiterated | Barrington Research | Outperform |
| Aug-06-15 | Reiterated | Barrington Research | Outperform |
| Mar-27-15 | Initiated | Dougherty & Company | Buy |
| Feb-25-14 | Initiated | Laidlaw | Buy |
| Aug-01-13 | Upgrade | Feltl & Co. | Buy → Strong Buy |
| Nov-12-12 | Reiterated | Barrington Research | Outperform |
View All
Surmodics Inc Stock (SRDX) Latest News
What earnings revisions data tells us about Surmodics Inc.Weekly Risk Summary & Community Verified Trade Signals - newser.com
Is it time to cut losses on Surmodics Inc.Portfolio Update Report & Fast Momentum Stock Entry Tips - newser.com
Surmodics to present updated data on Pounce thrombectomy system - Investing.com
Key metrics from Surmodics Inc.’s quarterly dataMarket Activity Report & Long-Term Safe Investment Plans - newser.com
Surmodics Announces PROWL Registry 160-Patient Data to be Presented in Industry-Sponsored Session at VIVA Conference on November 3 - Yahoo Finance
Can Surmodics Inc. stock reach $100 price targetJuly 2025 News Drivers & Stock Market Timing Techniques - newser.com
Can Surmodics Inc. stock deliver sustainable ROEWeekly Trade Summary & AI Enhanced Trade Execution Alerts - newser.com
Is Surmodics Inc. stock resilient to inflationWeekly Market Outlook & Accurate Entry/Exit Alerts - newser.com
Will Surmodics Inc. stock return to pre crisis levelsWeekly Stock Recap & AI Powered Trade Plan Recommendations - newser.com
Is Surmodics Inc. stock a safe investment in uncertain markets2025 Stock Rankings & Free Real-Time Volume Trigger Notifications - newser.com
How institutional ownership impacts Surmodics Inc. stock2025 Valuation Update & Risk Controlled Stock Pick Alerts - newser.com
Published on: 2025-11-01 01:11:15 - newser.com
Is Surmodics Inc. stock entering bullish territoryJuly 2025 Short Interest & Growth Focused Entry Reports - newser.com
Regression analysis insights on Surmodics Inc. performanceEarnings Beat & Proven Capital Preservation Methods - newser.com
Published on: 2025-10-31 04:30:06 - newser.com
Published on: 2025-10-31 04:03:38 - newser.com
Surmodics (SRDX) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
How to interpret RSI for Surmodics Inc. stockJuly 2025 Closing Moves & Proven Capital Preservation Tips - newser.com
Surmodics Announces Results from Sex-Specific Analysis of the PROWL Registry Study of Real-World Limb Ischemia Patients Treated with the Pounce™ Thrombectomy Platform - BioSpace
Surmodics (SRDX) PROWL Study Highlights Success in Thrombectomy Procedures - GuruFocus
Surmodics, Inc. (NASDAQ:SRDX) Given Average Rating of "Hold" by Analysts - MarketBeat
Published on: 2025-10-29 03:26:33 - fcp.pa.gov.br
Surmodics Announces PROWL Registry Sex-Specific Data to be Presented at TCT Conference on October 28 - BioSpace
Sectors Review: Will Surmodics Inc. stock reach all time highs in 2025Dip Buying & Free Community Consensus Stock Picks - fcp.pa.gov.br
Aug Chart Watch: Will Surmodics Inc. stock reach all time highs in 2025July 2025 Momentum & Safe Capital Growth Stock Tips - fcp.pa.gov.br
Published on: 2025-10-27 15:15:37 - Fundação Cultural do Pará
Surmodics' PROWL Registry data to unveil new clinical insights - Traders Union
Surmodics Inc Stock (SRDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.84%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):